These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systemic antifungal drugs. Med Lett Drugs Ther; 1997 Sep; 39(1009):86-8. PubMed ID: 9305292 [No Abstract] [Full Text] [Related]
6. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. Van Cutsem J Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313 [TBL] [Abstract][Full Text] [Related]
7. Azole antifungal drugs in treatment of coccidioidomycosis. Graybill JR Semin Respir Infect; 1986 Mar; 1(1):53-60. PubMed ID: 3317599 [TBL] [Abstract][Full Text] [Related]
8. Current drug therapy of systemic mycoses: a review. Yonga G East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of systemic fungal infections. Walsh TJ Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615 [TBL] [Abstract][Full Text] [Related]
10. [Commonly used antifungal agents in the treatment of systemic mycoses]. Berenguer Berenguer J Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308 [No Abstract] [Full Text] [Related]
11. [Anti-Candida activity of azoles]. Van Cutsem J; Van Gerven F; Janssen PA Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810 [TBL] [Abstract][Full Text] [Related]
12. Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis. Knoper SR; Galgiani JN Infect Dis Clin North Am; 1988 Dec; 2(4):861-75. PubMed ID: 3062091 [TBL] [Abstract][Full Text] [Related]
13. [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States]. Hostetler JS; Stevens DA Med Klin (Munich); 1991 Dec; 86 Suppl 1():8-10. PubMed ID: 1663205 [TBL] [Abstract][Full Text] [Related]
15. Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Viviani MA Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314 [TBL] [Abstract][Full Text] [Related]
16. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Grant SM; Clissold SP Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949 [TBL] [Abstract][Full Text] [Related]
17. Therapy for fungal infections. Sarosi GA; Davies SF Mayo Clin Proc; 1994 Nov; 69(11):1111-7. PubMed ID: 7967767 [TBL] [Abstract][Full Text] [Related]
18. Treatment of systemic mycoses in patients with AIDS. Graybill JR Arch Med Res; 1993; 24(4):403-12. PubMed ID: 8118165 [TBL] [Abstract][Full Text] [Related]
19. Role of azoles in antifungal therapy. Kauffman CA Clin Infect Dis; 1996 May; 22 Suppl 2():S148-53. PubMed ID: 8722843 [TBL] [Abstract][Full Text] [Related]
20. The triazole antifungal agents: a review of itraconazole and fluconazole. Bailey EM; Krakovsky DJ; Rybak MJ Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]